DANIEL WAGNER

Profile

First Name

: DANIEL

Middle Name

:

Last Name

: WAGNER

Related Companies
Titles
Company Name
Related People
DIRECTOR
INNOVATIENT SOLUTIONS, INC.
MARCEL GAMACHE, JOHN HANNON, JOLINDA LAMBERT
DIRECTOR
REMOTEREALITY CORP
ROBERT ANDERSON, KHALED EL-MARSAFY, MATTHEW MCCOOE, DENNIS MCGINN, RAGHU MENON, PATRICK O-NEILL, VENKAT PERI, MICHAEL ZWOLINSKI, MIKE ZWOLINSKI
DIRECTOR
NEW HAVEN PHARMACEUTICALS, INC.
LARRY DILLAHA, CHRISTOPHER ECKLUND, PATRICK FOURTEAU, SCOTT KOZAK, NANCY MOTOLA, HARRY PENNER, JR., HARRY H. PENNER, JR., WILLIAM SESSA, THEODORE STANLEY, ROB STERLING
DIRECTOR
CMDBIOSCIENCE,INC.
DAVID AUDIE, JOSEPH AUDIE, KONSTANTINE DRAKONAKIS
DIRECTOR
SOFT TISSUE REGENERATION, INC.
MICHAEL B ARONSON, JEFFERY A. BAIRD, KONSTANTINE DRAKONAKIS, RICHARD EMMITT, CHARLES HART, PAUL HERMES, ROBERT S LANGER, CATO LAURENCIN, CATO T LAURENCIN, SACHA LEVY, DANE MILLER, NICHOLAS PACHUDA, JOSEPH W REILLY, KEVIN ROCCO, KEVIN A ROCCO, KEVIN A. ROCCO, LEVY SACHA, RUSSELL E TWEEDDALE
DIRECTOR
ISOPLEXIS CORP
JOHN CONLEY, MICHAEL EGHOLM, RONG FAN, JAMES HEATH, GREGORY HO, SHARON KEDAR, SEAN MACKAY, SEAN MCKAY, JOHN STRAHLEY
EXECUTIVE OFFICER
BARPAY, LLC
JOE DE PINTO, JOSEPH DE PINTO
DIRECTOR
CORNOVUS PHARMACEUTICALS INC.
BRUCE LIANG, GLENN MATTES, RAYMOND NEAG, TIMOTHY SHANNON, R. MARK VAN ALLEN, ROBERT MARK VAN ALLEN
DIRECTOR
BIOREZ, INC.
MICHAEL B ARONSON, JEFFERY A. BAIRD, KONSTANTINE DRAKONAKIS, RICHARD EMMITT, CHARLES HART, PAUL HERMES, ROBERT S LANGER, CATO LAURENCIN, CATO T LAURENCIN, SACHA LEVY, DANE MILLER, NICHOLAS PACHUDA, JOSEPH W REILLY, KEVIN ROCCO, KEVIN A ROCCO, KEVIN A. ROCCO, LEVY SACHA, RUSSELL E TWEEDDALE
DIRECTOR
AZITRA INC
RICAHRD ANDREWS, RICHARD ANDREWS, LUCIO IANNONE, NAVEEN KRISHAN, ANDREW MCCLARY, CAIN MCCLARY, AZIM MUNIVAR, STELLA ROBERTSON, FRANCISCO SALVA, TRAVIS WHITFILL
DIRECTOR
ALLOMEK THERAPEUTICS, LLC
N/A CHEMINPHARMA LLC, JASON FISHERMAN, UDAY KHIRE
DIRECTOR
PROTEOWISE INC.
BENJAMIN COMB, BENJAMIN D. COMB, ERIK GUNTHER, DAVID SMOLLER
EXECUTIVE OFFICER
HASTE, INC.
JOSEPH DEPINTO
DIRECTOR
TANGEN BIOSCIENCES, INC.
CHRISTOPHER BENOIT, RICHARD BIRKMEYER, PHD, RICHARD C. BIRKMEYER, PHD, BRIAN CHIRICO, JOHN DAVIDSON, VANCE V. KERSHNER, ALAN LEVIN, CHRISTOPHER MCLEOD, JOHN RICHARD NOBILE, DAN WAGNER
DIRECTOR
MITOTHERAPEUTIX, LLC
FENEL ELOI, ROBERT HEMLEY, ROBERT HENNESSEY, JOHN TALLEY, JOHN V. TALLEY
DIRECTOR
INTUS BIOSCIENCES, LLC
PAUL DENSLOW, MARK DRISCOLL, MARK D. DRISCOLL, DONNA GALLUZZO, THOMAS JARVIE, THOMAS P JARVIE, THOMAS P. JARVIE, H. MARK LUNENBURG, FRANK MARCO, FRANK J. MARCO, WILLIAM MCKENZIE, ALAN MENDELSON, PATRICK O-NEILL, MATT WATSON, DAVID WURZER
EXECUTIVE OFFICER
REZOLVE AI PLC
DIRECTOR
ENRICH BIOSYSTEMS INC.
CYNTHIA GREEN, CHRISTOPHER MCLEOD, JAY TEICH, DONG WANG, QI ZHAO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-11-13 
2025-10-10
D
Link
OTHER TECHNOLOGY 
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] 
DECLINE TO DISCLOSE 
Equity 
2025-09-25 
2025-08-06
D
Link
OTHER TECHNOLOGY 
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] 
DECLINE TO DISCLOSE 
Equity 
2025-07-25 
2025-05-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-15 
2025-05-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-12 
2024-12-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-06 
2023-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-05-26 
2021-11-15
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-08-17 
2021-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-06-14 
2021-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-31 
2021-01-08
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-30 
2021-01-08
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-30 
2020-09-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2020-03-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-23 
2020-02-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-21 
2019-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2018-11-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-08 
2018-04-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-04-13 
2018-03-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-01 
2017-08-10
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-20 
2016-12-05
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2016-11-22 
2016-08-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-01 
2016-08-11
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2016-08-10 
2016-06-29
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-17 
2015-11-04
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-11-19 
2015-09-03
D/A
Link
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2015-08-04 
2015-08-17
D
Link
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2015-08-04 
2015-07-15
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2015-06-30 
2015-05-29
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-28 
2014-11-07
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-11-19 
2014-10-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-08 
2014-07-01
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-26 
2013-12-05
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-11-19 
2013-07-02
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-29 
2013-06-10
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-29 
2012-12-13
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-11-28 
2012-12-03
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-16 
2012-10-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-19 
2012-03-20
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-20 
2011-10-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-22 
2011-05-05
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-20